Advances: Bioinformatics applied to development & evaluation of boron-containing compounds

May 01, 2017

In the last few decades, research into boron-containing compounds (BCCs) has notably increased in medicinal chemistry. Multiple maladies are now targeted by means of BCCs. Some successful cases are noteworthy in the treatment of cancer and infectious diseases.

Since bioinformatics tools have become a common and efficient methodology for drug design and materials science, their application to the study of BCCs is expected to intensify.That is clearly observed in the development of BCCs for being used in the medical field.

This review compiles information about the use of computational technology to elucidate the chemical-biological effects of BCCs, whether coming from natural sources or drug development strategies.

A broad range of computational approaches facilitate pharmacochemical analysis of BCCs. Most of these approaches focus on the essential parameters of a boron atom, the reasons for an experimental event, and the shared pharmacodynamics, pharmacokinetics or toxic effects of components of a group of BCCs. The article conveys information about pioneering advances and some studies of interatomic interactions between boron and any element related to organic chemistry. It also covers biological effects of BCCs.

Some studies have examined the properties of the boron atom in molecules for designing drugs and biomaterials, while other projects have attempted to identify the best quantitative structure-activity relationship for a specific target. However, the lack of some experimental and theoretical data limit the use of boron in theoretical assays.

A final remark is made as to the potential impact on BCC research that could result from advances in bioinformatics. The potential of new advances in bioinformatics applied to study of BCCs would let us to understand in better way the electromagnetic behavior of the boron atom as well as the biochemical behavior of molecules in its structure under the conditions found in the environment for interactions triggering biological effects.

Some lacking parameters for boron for in silico assays about its biological effects, elemental properties, or parameters related to the element in an organometallic molecule, present an opportunity for research groups studying BCCs around the word.
Erik Andrade-Jorge, Ana Karen García-Ávila, Ana Lilia Ocampo-Néstor, José Guadalupe Trujillo-Ferrara and Marvin Antonio Soriano-Ursúa.

Escuela Superior de Medicina, Instituto Politécnico Nacional. Plan de San Luis y Salvador Díaz Mirón s/n, Casco de Santo Tomás, México City 11340, México.

Reference: Andrade-Jorge E. et al. (2017).Advances of bioinformatics applied to development and evaluation of boron-containing compounds, Curr. Org.Chem., DOI 10.2174/1385272821666170427124336

Bentham Science Publishers

Related Bioinformatics Articles from Brightsurf:

Glyphosate may affect human gut microbiota
More than half of bacterial species in the core of the human gut microbiome are potentially sensitive to glyphosate, shows new research.

Next-gen bioinformatics tool enables big data analysis without programming expertise
A new data analysis tool developed by MD Anderson researchers incorporates a user-friendly, natural-language interface to aid biomedical researchers without bioinformatics or programming expertise to conduct intuitive data.

Embracing bioinformatics in gene banks
Scientists from the IPK have explored, within a perspective paper, the upcoming challenges and possibilities of the future of gene banks.

New bioinformatics tool identifies and classifies CRISPR-Cas systems
Designed to improve the utility and availability of increasingly diverse CRISPR-Cas genome editing systems, the new CRISPRdisco automated pipeline helps researchers identify CRISPR repeats and cas genes in genome assemblies.

AMP Iissues consensus guideline recommendations for NGS bioinformatics pipelines
The Association for Molecular Pathology, the premier global, non-profit molecular diagnostics professional society, today published 17 consensus recommendations to help clinical laboratory professionals achieve high-quality sequencing results and deliver better patient care.

Advances: Bioinformatics applied to development & evaluation of boron-containing compounds
The interest for developing boron-containing compounds as drugs is increasing after some successful cases.

When life sciences become data sciences
The University of Freiburg offers Europe-wide infrastructure and service in Bioinformatics.

Bioinformatics brings to light new combinations of drugs to fight breast cancer
A bioinformatics analysis of pairing 64 drugs used to treat breast cancer allows researchers at IRB Barcelona to identify 10 previously untested combinations with potential to tackle resistance to breast cancer treatment.

New bioinformatics tool tests methods for finding mutant genes that 'drive' cancer
Computational scientists and cancer experts have devised bioinformatics software to evaluate how well current strategies distinguish cancer-promoting mutations from benign mutations in cancer cells.

EDGE bioinformatics brings genomics to everyone
A new bioinformatics platform called Empowering the Development of Genomics Expertise (EDGE) will help democratize the genomics revolution by allowing users with limited bioinformatics expertise to quickly analyze and interpret genomic sequence data.

Read More: Bioinformatics News and Bioinformatics Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to